Advanced Pulmonary Sarcoidosis: Closing the Gap to Better Management

Session Format

Live Webinar

Session Type

Case-based Discussion Session

Topic Area

ILD and Friends

Session Date

October 18, 2020 7:30 AM - 8:30 AM

Description

Advanced pulmonary sarcoidosis (APS) occurs in approximately 5% of sarcoidosis patients, and it accounts for most of the mortality, morbidity, and healthcare use. New and emerging advances can aid clinicians in managing the complications and pathophysiologic processes of APS. These include the use of inflammatory markers, new insights into sarcoidosis-associated pulmonary fibrosis and pulmonary hypertension, infectious complications, and lung transplantation. APS would be presented with a focus on gaps in current knowledge, recent advances, and future research and clinical directions. The goal is to provide participants with evidence-based strategies to assist in better management of APS.

Learning Objective 1

Understand the importance of advanced pulmonary sarcoidosis.

Learning Objective 2

Discuss a holistic approach to the management of patients with APS.

Summary


Availability:	On-Demand


Cost:	FREE


Credit Offered:	1 CME Credit